TOBIRA THERAPEUTICS INC Inactive Instrument
Company Tobira Therapeutics Inc Nasdaq
Equities
US75874Q1076
Biotechnology & Medical Research
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 53 | - |
Scott Reents
DFI | Director of Finance/CFO | 57 | - |
| Corporate Secretary | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 18,821,231 | 18,577,505 ( 98.71 %) | 0 | 98.71 % |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +8.96% | 105B | |
| -1.43% | 104B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +38.61% | 12.63B | |
| +313.59% | 8.49B |
